A detailed history of Granite Fo LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Granite Fo LLC holds 1,250 shares of LLY stock, worth $959,700. This represents 0.63% of its overall portfolio holdings.

Number of Shares
1,250
Previous 1,250 -0.0%
Holding current value
$959,700
Previous $1.13 Billion 2.15%
% of portfolio
0.63%
Previous 0.72%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$724.87 - $909.04 $906,087 - $1.14 Million
1,250 New
1,250 $1.13 Billion
Q3 2023

Sep 05, 2024

SELL
$434.7 - $599.3 $76,072 - $104,877
-175 Reduced 12.28%
1,250 $671 Million
Q2 2023

Sep 05, 2024

SELL
$350.74 - $468.98 $1.15 Million - $1.54 Million
-3,275 Reduced 69.68%
1,425 $668 Million
Q1 2023

Sep 05, 2024

BUY
$310.63 - $364.82 $1.07 Million - $1.26 Million
3,450 Added 276.0%
4,700 $1.86 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Granite Fo LLC Portfolio

Follow Granite Fo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Fo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Fo LLC with notifications on news.